Back to all studies
CompletedNCT06963580

MI078 Capsule for depression

This study is completed in China. It is testing MI078 Capsule for depression.

DepressionDrugFrom 18 Years to 45 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether MI078 Capsule may be useful for adults experiencing depression.

What would participation involve?

Participants may receive MI078 Capsule, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in China.

Who is it mainly for?

This study appears to be mainly for adults with depression.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: September 9, 2024
Recruitment status
Completed
Enrollment listed in the registry
72
Sponsor
Nanjing Minova Pharmaceutical Co., Ltd.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
China
Age range
From 18 Years to 45 Years
Official registry ID
NCT06963580
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of MI078 Capsule in Patients With Postpartum Depression

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

China · 21 sites
  • The Affiliated Beijing Anding Hospital of Capital Medical University, Wuhu Hospital
    Wuhu, Anhui
    Site status: Not listed — confirm with the team
  • Beijing HuiLongGuan Hospital
    Beijing, Beijing Municipality
    Site status: Not listed — confirm with the team
  • Xiamen Xian Yue Hospital
    Xiamen, Fujian
    Site status: Not listed — confirm with the team
  • Shunde Hospital of Southern Medical University
    Foshan, Guangdong
    Site status: Not listed — confirm with the team
  • The First Affiliated Hospital of Jinan University
    Guangzhou, Guangdong
    Site status: Not listed — confirm with the team
  • Guangxi Zhuang Autonomous Region People's Hospital
    Nanning, Guangxi
    Site status: Not listed — confirm with the team
  • The People's Hospital of Guizhou Province
    Guiyang, Guizhou
    Site status: Not listed — confirm with the team
  • The First Hospital of Hebei Medical University
    Shijiazhuang, Hebei
    Site status: Not listed — confirm with the team
  • Xingtai People's Hospital
    Xingtai, Hebei
    Site status: Not listed — confirm with the team
  • The First Affiliated Hospital of Nanchang University
    Nanchang, Jiangxi
    Site status: Not listed — confirm with the team
  • Shanghai Mental Health Center
    Shanghai, Shanghai Municipality
    Site status: Not listed — confirm with the team
  • Shanghai Pudong New Area Mental Health Center
    Shanghai, Shanghai Municipality
    Site status: Not listed — confirm with the team
  • Linfen Central Hospital
    Linfen, Shanxi
    Site status: Not listed — confirm with the team
  • The First Hospital of Shanxi Medical University
    Taiyuan, Shanxi
    Site status: Not listed — confirm with the team
  • Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
    Chengdu, Sichuan
    Site status: Not listed — confirm with the team
  • First Affiliated Hospital of Kunming Medical University
    Kunming, Yunnan
    Site status: Not listed — confirm with the team
  • The First People's Hospital of Hangzhou
    Hangzhou, Zhejiang
    Site status: Not listed — confirm with the team
  • The Second Affiliated Hospital of Zhejiang University School of Medicine
    Hangzhou, Zhejiang
    Site status: Not listed — confirm with the team
  • The Affiliated Kangning Hospital of Ningbo University
    Ningbo, Zhejiang
    Site status: Not listed — confirm with the team
  • The First Affiliated Hospital of Ningbo University
    Ningbo, Zhejiang
    Site status: Not listed — confirm with the team
  • The First Affiliated Hospital of Wenzhou Medical University
    Wenzhou, Zhejiang
    Site status: Not listed — confirm with the team

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT06963580. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving MI078 capsule dose 1, MI078 capsule dose 2, placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with depression; age range: From 18 Years to 45 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Nanjing Minova Pharmaceutical Co., Ltd., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me